A new report reveals FDA inspectors found a lack of adequate microbial controls at a Novo Nordisk plant in the U.S., which manufactures the active ingredient for Ozempic and Wegovy.
Some anesthesiologists are saying recent ASA guidelines don't go far enough to prevent Ozempic stomach risks during surgery.
The makers of Wegovy claim the weight loss drug can decrease the risk of serious heart problems, such as stroke and heart attacks.
Eli Lilly may face a growing number of Mounjaro lawsuits, as users of the new drug report increasing incidents of stomach paralysis linked to the diabetes medication.
A gastroparesis lawsuit filed against the makers of Ozempic and Mounjaro claim the diabetes injections should warn patients and their doctors of the risks of severe stomach problems.
European regulators have launched an investigation into Ozempic suicide risks following reports of users experiencing desires to harm themselves in Iceland.
New guidance calls for patients to stop taking Ozempic, Wegovy and similar drugs before surgery due to risks of vomiting and suffocation.
Some diabetes drugs, like Ozempic and Wegovy, may be linked to increased thyroid cancer risks, European drug regulators warn.
A pair of federal judges have dismissed two Medtronic MiniMed lawsuits, saying plaintiffs claims against the manufacturer are preempted by federal law.
The findings of a new study indicate those with diabetes face a higher risk of sepsis, death and other risks from Stevens-Johnson Syndrome.
